1.80
+0.15(+9.09%)
Currency In USD
| Previous Close | 1.65 |
| Open | 1.8 |
| Day High | 1.84 |
| Day Low | 1.78 |
| 52-Week High | 5.24 |
| 52-Week Low | 1.61 |
| Volume | 12,152 |
| Average Volume | 42,077 |
| Market Cap | 74.01M |
| PE | -1.42 |
| EPS | -1.27 |
| Moving Average 50 Days | 2.2 |
| Moving Average 200 Days | 3.26 |
| Change | 0.15 |
If you invested $1000 in Elutia Inc. (ELUT) since IPO date, it would be worth $124.14 as of June 01, 2025 at a share price of $1.8. Whereas If you bought $1000 worth of Elutia Inc. (ELUT) shares 3 years ago, it would be worth $291.73 as of June 01, 2025 at a share price of $1.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
— Innovative approach accelerates new product development and testing —SILVER SPRING, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced th
Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
Move expected to drive both top-line growth and gross margin improvement SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced it
Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 financial results after marke